» Articles » PMID: 39196440

Inflammatory Aspects of Alzheimer's Disease

Overview
Specialty Neurology
Date 2024 Aug 28
PMID 39196440
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer´s disease (AD) stands out as the most common chronic neurodegenerative disorder. AD is characterized by progressive cognitive decline and memory loss, with neurodegeneration as its primary pathological feature. The role of neuroinflammation in the disease course has become a focus of intense research. While microglia, the brain's resident macrophages, have been pivotal to study central immune inflammation, recent evidence underscores the contributions of other cellular entities to the neuroinflammatory process. In this article, we review the inflammatory role of microglia and astrocytes, focusing on their interactions with AD's core pathologies, amyloid beta deposition, and tau tangle formation. Additionally, we also discuss how different modes of regulated cell death in AD may impact the chronic neuroinflammatory environment. This review aims to highlight the evolving landscape of neuroinflammatory research in AD and underscores the importance of considering multiple cellular contributors when developing new therapeutic strategies.

Citing Articles

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers.

Thal D, Poesen K, Vandenberghe R, De Meyer S Mol Neurodegener. 2025; 20(1):33.

PMID: 40087672 DOI: 10.1186/s13024-025-00819-y.


Pre-surgical memory impairment is associated with risk of postoperative cognitive dysfunction in a large geriatric cohort.

Granger K, Spies C, Caswell S, Hadzidiakos D, Speidel S, Slooter A JAR Life. 2025; 14:100002.

PMID: 40046643 PMC: 11863874. DOI: 10.1016/j.jarlif.2025.100002.


How the gut microbiota impacts neurodegenerative diseases by modulating CNS immune cells.

Schaible P, Henschel J, Erny D J Neuroinflammation. 2025; 22(1):60.

PMID: 40033338 PMC: 11877772. DOI: 10.1186/s12974-025-03371-0.


Brain Glycogen-Its Metabolic Role in Neuronal Health and Neurological Disorders-An Extensive Narrative Review.

Beltran-Velasco A Metabolites. 2025; 15(2).

PMID: 39997753 PMC: 11857135. DOI: 10.3390/metabo15020128.


Alzheimer's Disease: Exploring Pathophysiological Hypotheses and the Role of Machine Learning in Drug Discovery.

Dominguez-Gortaire J, Ruiz A, Porto-Pazos A, Rodriguez-Yanez S, Cedron F Int J Mol Sci. 2025; 26(3).

PMID: 39940772 PMC: 11816687. DOI: 10.3390/ijms26031004.


References
1.
Acosta C, Anderson H, Anderson C . Astrocyte dysfunction in Alzheimer disease. J Neurosci Res. 2017; 95(12):2430-2447. DOI: 10.1002/jnr.24075. View

2.
Carlos Acosta J, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton J . A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013; 15(8):978-90. PMC: 3732483. DOI: 10.1038/ncb2784. View

3.
Alonso A, Grundke-Iqbal I, Iqbal K . Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med. 1996; 2(7):783-7. DOI: 10.1038/nm0796-783. View

4.
Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T . Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015; 18(11):1584-93. PMC: 4694577. DOI: 10.1038/nn.4132. View

5.
Avila-Munoz E, Arias C . When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease. Ageing Res Rev. 2014; 18:29-40. DOI: 10.1016/j.arr.2014.07.004. View